BSE · BRAWN
Brawn Biotech Limited (BRAWN) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,750
of 5,047 stocks
▲ 61W▼ 731M
Peak #4,630 · 02 Oct 2026
Brawn Biotech Limited, a microcap Healthcare business, trades at an undemanding earnings multiple, is growing revenue rapidly, and generates a high return on equity.
Market Cap
6.86 Cr
P/E Ratio
7.01
P/B Ratio
1.58
ROE
21.67%
ROCE
0.10%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 5.62 Cr | 6.08 Cr | 1.98 Cr | 4.31 Cr |
| Net Profit | 3.03 L | 15.43 L | 58.33 L | 4.98 L |
| EPS | 0.12 | 0.52 | 1.95 | 0.17 |
| Operating Profit | 3.17 L | 15.45 L | -35.39 L | 4.99 L |
Shareholding pattern
Promoter
52.94%
Public
47.06%
PUBLIC BREAKDOWN
FII
0.00%
DII
0.35%
MF (within DII)
0.35%
Individuals
31.74%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Sep 2018 | Dividend | Final Dividend - Rs. - 1.0000 |
| 14 Sep 2017 | Dividend | Final Dividend - Rs. - 1.5000 |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.